Skip to main content
Cancer Explained
Donate
Beginner 5 min readSource checked

Metastatic Cervical Cancer: What to Ask

Questions to ask about metastatic cervical cancer, including treatment goals, symptoms, trials, and support.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source

NCI PDQ — Cervical Cancer Treatment (Patient Version)

Bearded man carefully handles a swab and tube from an opened at-home test kit on a bathroom counter.
At-Home Test Kit

Key fact

NCI's five options here are immunotherapy, radiation with chemotherapy, palliative drug treatment, pelvic exenteration, and early-phase trials.

The short answer

For stage IVB and recurrent cervical cancer NCI lists five options. Apart from immunotherapy, they are unlikely to cure and are used mostly to ease symptoms, so ask what each treatment is for.

  • NCI's five options here are immunotherapy, radiation with chemotherapy, palliative drug treatment, pelvic exenteration, and early-phase trials.

  • Pembrolizumab was approved for recurrent or metastatic disease with PD-L1 expression at a combined positive score of 1 or higher.

  • Tisotumab vedotin, an infusion given every three weeks, is an option after prior treatment; ocular events occurred in 52.8 percent.

  • A tumor pressing on a ureter can block a kidney, and draining it may need to come before drug treatment.

Choose how you want to understand this

The full explanation.

What NCI lists for advanced cervical cancer

For stage IVB and recurrent disease, NCI gives five options: immunotherapy, radiation with chemotherapy, drug treatment for symptom control, pelvic exenteration, and early-phase trials.

It adds one sentence that shapes the whole conversation. Apart from immunotherapy, which has given longer time without the disease progressing, the other options are unlikely to cure and are mostly used to ease symptoms.

That is not a reason to give up on treatment. It is a reason to ask what each treatment is for.

What the PD-L1 score decides

Pembrolizumab was approved for recurrent or spreading cervical cancer whose tumor shows PD-L1. The threshold NCI gives is a combined positive score of 1 or higher.

That score comes from staining a piece of your tumor. Ask whether the test was done, what the number was, and on which sample.

If chemotherapy stops working

NCI describes tisotumab vedotin given by infusion every three weeks, at an amount based on body weight, compared with chemotherapy chosen by the doctor, in recurrent cervical cancer.

Eye problems were the side effect that stood out. NCI reports ocular events in 52.8 percent of people in that arm. Ask what eye monitoring and eye drops would be needed before you start.

A blocked kidney can come first

A tumor in the pelvis can press on the tube from a kidney. If that happens, draining the kidney may need to come before any drug treatment.

Ask whether either kidney is blocked. Ask whether a stent or a drain through the skin is needed, and how soon.

Bleeding, discharge and comfort

Radiation is on NCI's list here, and one of its jobs is control of bleeding and discharge. Ask whether a short course aimed at the tumor itself would help you now.

Ask which symptom bothers you most, and make sure that symptom is named in the plan.

Questions to ask

  • What is my PD-L1 combined positive score?
  • Does that open up pembrolizumab, alone or with chemotherapy?
  • What is the goal of the treatment you are recommending?
  • If chemotherapy stops working, is tisotumab vedotin an option?
  • What eye monitoring would that need?
  • Is either of my kidneys blocked right now?
  • Can radiation help my bleeding while other treatment goes on?

Ask what happens if you say no to a given step. A good team will answer that without flinching.

When to get help sooner

  • Call 911 or go to an emergency department if vaginal bleeding is heavy enough that pads cannot keep up, or if bleeding comes with dizziness, fainting or a racing heart. Go too if you cannot pass urine at all, or if you have severe breathlessness or chest pain.
  • Treat a temperature of 100.4°F (38°C) or higher as an emergency if you are having chemotherapy, chemoradiation, or tisotumab vedotin. Phone your cancer team the moment you see the reading, whatever the hour, rather than leaving it for a same-day call; CDC describes a fever during chemotherapy as a medical emergency because your infection defences are down. If nobody picks up quickly, head to an emergency department and say at the desk that you are on cancer treatment. A fever with no cancer treatment behind it can still go through the same-day route.
  • Call your care team the same day if you have pain in your side or lower back with much less urine than usual, which can mean a ureter is blocked and the kidney behind it is backing up. If you are on tisotumab vedotin, call the same day for eye pain, redness, blurred vision or new sensitivity to light. That drug can damage the surface of the eye. Also call the same day for a blistering or peeling rash, or a new cough or breathlessness.
  • Call your care team within a day or two if discharge becomes foul smelling, one leg is swelling, or bleeding is steady but light. Do the same for new numbness or tingling in your hands or feet, or for pelvic pain your current painkillers are no longer holding.

Cancer Staging and Biomarker Testing explain the terms behind a metastatic cervical cancer diagnosis. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor cover the choices that come next with metastatic cervical cancer.

Where this comes from

These questions were drawn from current patient guidance for cervical cancer:

Words to know

Tap any term to see what it means.

Browse the full glossary →

An illustration: dNA strand and cell beside blood sample vials

Common questions

Is treatment still worth having if it will not cure the cancer?

NCI says that apart from immunotherapy, which has given prolonged disease-free survival, the options here are unlikely to cure and are mostly used for palliation. That is a reason to ask what each treatment is for, not a reason to skip it.

What decides whether I can have pembrolizumab?

A PD-L1 combined positive score of 1 or higher, measured on tumor tissue. Ask whether the test was done, what the number was, and which sample it came from.

What monitoring does tisotumab vedotin need?

Eye monitoring. Ocular events were the standout side effect, at 52.8 percent in the trial NCI describes, so ask about eye checks and eye drops before starting.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.